BHST — BIOHARVEST SCIENCES INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1723464 ·
Last close
$2.16
Market Cap
$48.96M
52W High
$4.47
52W Low
$1.82
ADV30
49,286
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 8,507,000 | 5,037,000 | -1,834,000 | -2,641,000 | 45,558,000 | 19,167,000 | 22,535,000 |
| Dec 2025 | 9,066,000 | 5,225,000 | -1,121,000 | -2,204,000 | 47,665,000 | 23,025,000 | 22,217,000 |
| Sep 2025 | 9,067,000 | 5,570,000 | -920,000 | -2,513,000 | 35,188,000 | 10,966,000 | 27,453,000 |
| Jun 2025 | 8,515,000 | 5,086,000 | -1,815,000 | -4,080,000 | 27,798,000 | 3,727,000 | 32,021,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,226,000
Investing CF
$-2,365,000
Financing CF
$30,187,000
CapEx
$-2,355,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.67
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-107,553,000
Inventory
$4,559,000
Receivables
$2,243,000
ST Investments
—
EBIT TTM
$-8,336,000
Pretax Income TTM
$-11,059,000
Interest Exp TTM
$2,723,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$35,155,000
EBITDA
$-5,197,000
Free Cash Flow
$-11,084,875
Enterprise Value
$42,381,180
Total Cash
$20,168,000
Total Debt
$14,040,000
Shares Out
22,667,842
Trailing EPS
$-0.58
Book Value
$1.02
ROE
-103.3%
ROA
-9.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,508,000 | -5,575,000 | -11,135,000 | 47,665,000 | 22,217,000 | — | -7,226,000 |
| Dec 2024 | 25,188,000 | -6,989,000 | -12,913,000 | 25,001,000 | 23,671,000 | — | -6,684,000 |
| Dec 2023 | 12,672,000 | -9,966,000 | -12,564,000 | 15,002,000 | 29,855,000 | — | -8,522,000 |
| Dec 2022 | 5,498,000 | -10,612,000 | -11,236,000 | 9,393,000 | 15,322,000 | — | -9,241,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FLNA | FILANA THERAPEUTICS, INC. | $48.79M | $1.01 | — |
| EDSA | Edesa Biotech, Inc. | $49.23M | $5.11 | — |
| BYSI | BeyondSpring Inc. | $47.29M | $1.15 | — |
| VICP | Vicapsys Life Sciences, Inc. | $46.94M | $1.45 | — |
| MCRB | Seres Therapeutics, Inc. | $46.77M | $4.83 | — |
News headlines (Yahoo Finance, 1h cache)
Phathom Pharmaceuticals, Inc. (PHAT) Reports Break-Even Earnings for Q2
2026-07-30 14:30 · Yahoo
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
2026-07-29 12:00 · Yahoo
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-07-28 12:00 · Yahoo
BioHarvest lands $1.4M grant for AI-driven plant science
2026-07-15 12:49 · Yahoo
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
2026-07-15 11:30 · Yahoo
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
2026-07-13 12:00 · Yahoo
BioHarvest Sciences to Present at the 2026 BIO International Convention
2026-06-18 11:30 · Yahoo
BioHarvest Sciences and Tate & Lyle expand sweetener development program
2026-05-19 12:39 · Yahoo
BioHarvest (BHST) Q1 2026 Earnings Transcript
2026-05-18 13:08 · Yahoo
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
2026-05-18 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.